How many stocks are there of 4D Pharma?
The current number of stocks of 4D Pharma is 169.52 M undefined.
4D Pharma Stocks 2025
4D Pharma Stocks
169.52 M
Ticker
DDDD.L
ISIN
GB00BJL5BR07
WKN
A1XD45
In 2025, 4D Pharma had 169.52 M outstanding stocks, a 0% change from the 169.52 M stocks in the previous year.
The 4D Pharma Stocks history
| YEAR | NUMBER OF STOCKS (undefined GBP) |
|---|---|
| 2024e | 169.52 |
| 2023e | 169.52 |
| 2022e | 169.52 |
| 2021 | 169.52 |
| 2020 | 113.85 |
| 2019 | 65.49 |
| 2018 | 65.49 |
| 2017 | 65.08 |
| 2016 | 64.86 |
| 2015 | 59.82 |
| 2014 | 42 |
| 2013 | 36.55 |
| 2012 | 36.55 |
| 2011 | 36.55 |
4D Pharma shares outstanding GB00BJL5BR07 · A1XD45
The number of shares was 4D Pharma in 2024 — This indicates how many shares 169.52 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue 4D Pharma earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates 4D Pharma's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of 4D Pharma’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating 4D Pharma's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2011 | 36.55 M Aktien |
| 2012 | 36.55 M Aktien |
| 2013 | 36.55 M Aktien |
| 2014 | 42 M Aktien |
| 2015 | 59.82 M Aktien |
| 2016 | 64.86 M Aktien |
| 2017 | 65.08 M Aktien |
| 2018 | 65.49 M Aktien |
| 2019 | 65.49 M Aktien |
| 2020 | 113.85 M Aktien |
| 2021 | 169.52 M Aktien |
| 2022e | 169.52 M Aktien |
| 2023e | 169.52 M Aktien |
| 2024e | 169.52 M Aktien |
4D Pharma Aktienanalyse
What does 4D Pharma do?
4D Pharma PLC was founded in 2014 and is a biopharmaceutical company specializing in the research and development of innovative therapies for microbiome-related diseases. Although the company was founded in Scotland, its headquarters are now located in Leeds, England. The business model of 4D Pharma PLC is based on understanding and manipulating the microbiome, which encompasses all microorganisms in our body. The company is working on identifying and selecting specific strains of bacteria that can help fight or even cure diseases. By using advanced sequencing and analysis technologies, 4D Pharma PLC is able to better understand the complex interaction between the microbiome and the human body, leading to the development of innovative therapeutics. 4D Pharma PLC is divided into several divisions that focus on different areas of application. For example, the "Oncology" division is working on developing therapies for various types of cancer. Special strains of bacteria are identified that can specifically target and destroy tumors. These bacteria are either injected directly into the tumor or taken in capsule form to reach the tumor site. The goal is to ultimately develop a targeted and effective cancer therapy that is less invasive and burdensome for the patient compared to traditional treatments like chemotherapy or radiation. Another division of 4D Pharma PLC is the "Autoimmunity" department, which focuses on treating autoimmune diseases such as Crohn's disease, ulcerative colitis, or multiple sclerosis. Bacterial strains are identified that can regulate the immune system and reduce the pathological immune response in autoimmune diseases. These bacteria are administered in capsules to help build a healthy gut flora and strengthen the immune system. In addition to these two divisions, 4D Pharma PLC is also working on developing therapies for various other conditions such as asthma, allergic diseases, or Parkinson's disease. One promising product is the "MRx0518" medication, which specifically stimulates the immune system and can be used in the treatment of cancer and autoimmune diseases. Overall, 4D Pharma PLC has had an impressive success story in recent years. The company has raised millions of euros in investor funding to advance its research and development efforts. It has also entered into collaborations with various partners in the pharmaceutical and biotech industries to harness the potential of bacterial therapy. The company aims to develop groundbreaking therapies for diseases where traditional treatments have limitations. 4D Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating 4D Pharma's Shares Outstanding
4D Pharma's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in 4D Pharma’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding 4D Pharma’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in 4D Pharma’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about 4D Pharma stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of 4D Pharma are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of 4D Pharma evolved in recent years?
The number of shares of 4D Pharma has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. 4D Pharma as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of 4D Pharma?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does 4D Pharma pay?
Over the past 12 months, 4D Pharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, 4D Pharma is expected to pay a dividend of 0 GBP.
What is the dividend yield of 4D Pharma?
The current dividend yield of 4D Pharma is .
When does 4D Pharma pay dividends?
4D Pharma pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of 4D Pharma?
4D Pharma paid dividends every year for the past 0 years.
What is the dividend of 4D Pharma?
For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.
In which sector is 4D Pharma located?
4D Pharma is assigned to the 'Health' sector.
Wann musste ich die Aktien von 4D Pharma kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of 4D Pharma from 2/7/2025 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 2/7/2025.
When did 4D Pharma pay the last dividend?
The last dividend was paid out on 2/7/2025.
What was the dividend of 4D Pharma in the year 2024?
In the year 2024, 4D Pharma distributed 0 GBP as dividends.
In which currency does 4D Pharma pay out the dividend?
The dividends of 4D Pharma are distributed in GBP.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von 4D Pharma
Our stock analysis for 4D Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of 4D Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
